Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer

Abstract Women diagnosed with high-grade serous ovarian cancers (HGSOC) are still likely to exhibit a bad prognosis, particularly when suffering from HGSOC of the Mesenchymal molecular subtype (50% cases). These tumors show a desmoplastic reaction with accumulation of extracellular matrix proteins a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Virginie Mieulet, Camille Garnier, Yann Kieffer, Thomas Guilbert, Fariba Nemati, Elisabetta Marangoni, Gilles Renault, Foucauld Chamming’s, Anne Vincent-Salomon, Fatima Mechta-Grigoriou
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/de9d7830ae0941bbbd8cf54c4242beb8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:de9d7830ae0941bbbd8cf54c4242beb8
record_format dspace
spelling oai:doaj.org-article:de9d7830ae0941bbbd8cf54c4242beb82021-12-02T12:11:50ZStiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer10.1038/s41598-021-83685-02045-2322https://doaj.org/article/de9d7830ae0941bbbd8cf54c4242beb82021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83685-0https://doaj.org/toc/2045-2322Abstract Women diagnosed with high-grade serous ovarian cancers (HGSOC) are still likely to exhibit a bad prognosis, particularly when suffering from HGSOC of the Mesenchymal molecular subtype (50% cases). These tumors show a desmoplastic reaction with accumulation of extracellular matrix proteins and high content of cancer-associated fibroblasts. Using patient-derived xenograft mouse models of Mesenchymal and Non-Mesenchymal HGSOC, we show here that HGSOC exhibit distinct stiffness depending on their molecular subtype. Indeed, tumor stiffness strongly correlates with tumor growth in Mesenchymal HGSOC, while Non-Mesenchymal tumors remain soft. Moreover, we observe that tumor stiffening is associated with high stromal content, collagen network remodeling, and MAPK/MEK pathway activation. Furthermore, tumor stiffness accompanies a glycolytic metabolic switch in the epithelial compartment, as expected based on Warburg’s effect, but also in stromal cells. This effect is restricted to the central part of stiff Mesenchymal tumors. Indeed, stiff Mesenchymal tumors remain softer at the periphery than at the core, with stromal cells secreting high levels of collagens and showing an OXPHOS metabolism. Thus, our study suggests that tumor stiffness could be at the crossroad of three major processes, i.e. matrix remodeling, MEK activation and stromal metabolic switch that might explain at least in part Mesenchymal HGSOC aggressiveness.Virginie MieuletCamille GarnierYann KiefferThomas GuilbertFariba NematiElisabetta MarangoniGilles RenaultFoucauld Chamming’sAnne Vincent-SalomonFatima Mechta-GrigoriouNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-20 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Virginie Mieulet
Camille Garnier
Yann Kieffer
Thomas Guilbert
Fariba Nemati
Elisabetta Marangoni
Gilles Renault
Foucauld Chamming’s
Anne Vincent-Salomon
Fatima Mechta-Grigoriou
Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer
description Abstract Women diagnosed with high-grade serous ovarian cancers (HGSOC) are still likely to exhibit a bad prognosis, particularly when suffering from HGSOC of the Mesenchymal molecular subtype (50% cases). These tumors show a desmoplastic reaction with accumulation of extracellular matrix proteins and high content of cancer-associated fibroblasts. Using patient-derived xenograft mouse models of Mesenchymal and Non-Mesenchymal HGSOC, we show here that HGSOC exhibit distinct stiffness depending on their molecular subtype. Indeed, tumor stiffness strongly correlates with tumor growth in Mesenchymal HGSOC, while Non-Mesenchymal tumors remain soft. Moreover, we observe that tumor stiffening is associated with high stromal content, collagen network remodeling, and MAPK/MEK pathway activation. Furthermore, tumor stiffness accompanies a glycolytic metabolic switch in the epithelial compartment, as expected based on Warburg’s effect, but also in stromal cells. This effect is restricted to the central part of stiff Mesenchymal tumors. Indeed, stiff Mesenchymal tumors remain softer at the periphery than at the core, with stromal cells secreting high levels of collagens and showing an OXPHOS metabolism. Thus, our study suggests that tumor stiffness could be at the crossroad of three major processes, i.e. matrix remodeling, MEK activation and stromal metabolic switch that might explain at least in part Mesenchymal HGSOC aggressiveness.
format article
author Virginie Mieulet
Camille Garnier
Yann Kieffer
Thomas Guilbert
Fariba Nemati
Elisabetta Marangoni
Gilles Renault
Foucauld Chamming’s
Anne Vincent-Salomon
Fatima Mechta-Grigoriou
author_facet Virginie Mieulet
Camille Garnier
Yann Kieffer
Thomas Guilbert
Fariba Nemati
Elisabetta Marangoni
Gilles Renault
Foucauld Chamming’s
Anne Vincent-Salomon
Fatima Mechta-Grigoriou
author_sort Virginie Mieulet
title Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer
title_short Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer
title_full Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer
title_fullStr Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer
title_full_unstemmed Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer
title_sort stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/de9d7830ae0941bbbd8cf54c4242beb8
work_keys_str_mv AT virginiemieulet stiffnessincreaseswithmyofibroblastcontentandcollagendensityinmesenchymalhighgradeserousovariancancer
AT camillegarnier stiffnessincreaseswithmyofibroblastcontentandcollagendensityinmesenchymalhighgradeserousovariancancer
AT yannkieffer stiffnessincreaseswithmyofibroblastcontentandcollagendensityinmesenchymalhighgradeserousovariancancer
AT thomasguilbert stiffnessincreaseswithmyofibroblastcontentandcollagendensityinmesenchymalhighgradeserousovariancancer
AT faribanemati stiffnessincreaseswithmyofibroblastcontentandcollagendensityinmesenchymalhighgradeserousovariancancer
AT elisabettamarangoni stiffnessincreaseswithmyofibroblastcontentandcollagendensityinmesenchymalhighgradeserousovariancancer
AT gillesrenault stiffnessincreaseswithmyofibroblastcontentandcollagendensityinmesenchymalhighgradeserousovariancancer
AT foucauldchammings stiffnessincreaseswithmyofibroblastcontentandcollagendensityinmesenchymalhighgradeserousovariancancer
AT annevincentsalomon stiffnessincreaseswithmyofibroblastcontentandcollagendensityinmesenchymalhighgradeserousovariancancer
AT fatimamechtagrigoriou stiffnessincreaseswithmyofibroblastcontentandcollagendensityinmesenchymalhighgradeserousovariancancer
_version_ 1718394604881969152